Biovest International Inc., the subsidiary of Accentia Biopharmaceuticals Inc., USA has submitted the revision request to the US FDA for using the molecular reduction data in the ongoing pivotal phase 3 studies combined with the physical examination and CT scan evidence of gross tumor reduction for sustaining accelerated, provisional sanction of BiovaxID which is the custom-made anti-cancer vaccine for treating the follicular non-Hodgkin’s Lymphoma.
Non-Hodgkin’s Lymphoma – NHL...
| Currently you cannot purchase Biovex as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Biovex |
| Biovex Availability Subscription Form |
|
| |
| Note: We will email you when Biovex is available for sale online or in pharmacy in your country. |
|
|
|
